Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering ...
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).